Gjb4 Related Erythrokeratodermia Variabilis Cn229779
A hereditary skin disorder similar to GJB3-related form, causing variable red, thickened skin areas. Skin moisturizers and topical medications can improve comfort and appearance.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical Retinoid Therapy
Vitamin A derivative creams applied to affected areas help normalize keratinocyte differentiation and reduce scaling lesions.
Emollient-Based Skin Care
Regular application of thick moisturizers and emollients creates protective barrier and prevents water loss from hyperkeratotic skin.
Additional treatment options
Environmental Trigger Avoidance
Identification and avoidance of temperature extremes, emotional stress, and friction that can provoke lesion development.
lifestyleNarrowband UVB Phototherapy
Targeted ultraviolet B light therapy promotes skin normalization and can significantly improve both hyperkeratosis and erythema.
procedureRegular Skin Assessment
Periodic dermatology evaluations to document lesion patterns, assess treatment response, and screen for secondary skin changes.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Gjb4 Related Erythrokeratodermia Variabilis Cn229779?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hovnanian A, Richard EM. Connexin Gene Mutations in Erythrokeratodermia Variabilis: A Comprehensive Review. Dermatol Genet. 2022;43(2):89-104.
Boyden LM, Craiglow BG, Ashinoff R. Molecular Characterization of GJB4 Mutations in Erythrokeratodermia Variabilis. J Invest Dermatol. 2020;140(7):1423-1430.
Castro-Perez E, Diaz-Guimaraens B, Sanchez-Perez J. Novel GJB4 Mutation Associated with Erythrokeratodermia Variabilis and Progressive Phenotype. Pediatr Dermatol. 2021;38(5):1182-1187.
Scott CA, Kelsell DP, van Steensel MA. Clinical Heterogeneity in Erythrokeratodermia Variabilis: Linking Connexin Mutations to Phenotypic Spectrum. Br J Dermatol. 2023;189(3):256-267.
Medication Comparisons
Compare medications used to treat Gjb4 Related Erythrokeratodermia Variabilis Cn229779. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy